2267 — Yakult Honsha Share News
0.000.00%
- ¥821bn
- ¥767bn
- ¥486bn
Brief: Armas Pharmaceuticals Announcing Launch Of Oncology Injectable Irinotecan
Table: Yakult -2018/19 div forecast
Table: Yakult - 9-MTH group results
Table: Yakult - 6-MTH group results
Table: Yakult -Q1 group results
Brief: Verastem Oncology and Yakult Honsha sign agreement for development, commercialization of Duvelisib in Japan
Brief: R&I affirms Yakult Honsha's rating at "A+" and announces stable outlook -R&I
Table: Yakult -2017/18 parent results
Table: Yakult -2017/18 group results
French and Benelux stocks-Factors to watch on March 28
Brief: Danone Completes Sale Of Part Of Its Stake In Yakult For 1.3 Bln Eur
Food group Danone eyes further sales and profit growth for 2018 (updated)
Food group Danone eyes further sales and profit growth for 2018
Brief: Yakult Honsha buys back 4.9 mln shares for 36 bln yen and to retire treasury shares
Brief: Yakult Honsha to repurchase shares through ToSTNeT-3
Danone's Yakult sale points to a healthier future
Brief: Yakult Honsha says top shareholder to cut stake to 7.7 pct from 21.5 pct
Brief: Yakult Honsha to repurchase up to 3 pct shares and retire treasury shares
Food group Danone to sell 14 percent stake in Japan's Yakult (updated)